Cyclopenta[cd]pyrene

Suppliers

Names

[ CAS No. ]:
27208-37-3

[ Name ]:
Cyclopenta[cd]pyrene

[Synonym ]:
Acepyrylene
Cyclopenta[cd]pyrene

Chemical & Physical Properties

[ Density]:
1.4±0.1 g/cm3

[ Boiling Point ]:
438.3±12.0 °C at 760 mmHg

[ Melting Point ]:
174-177 °C(lit.)

[ Molecular Formula ]:
C18H10

[ Molecular Weight ]:
226.272

[ Flash Point ]:
209.2±13.7 °C

[ Exact Mass ]:
226.078247

[ LogP ]:
5.99

[ Vapour Pressure ]:
0.0±0.5 mmHg at 25°C

[ Index of Refraction ]:
1.935

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
GY5850000
CHEMICAL NAME :
Cyclopenta(cd)pyrene
CAS REGISTRY NUMBER :
27208-37-3
LAST UPDATED :
199710
DATA ITEMS CITED :
21
MOLECULAR FORMULA :
C18-H10
MOLECULAR WEIGHT :
226.28
WISWESSER LINE NOTATION :
L C5666 B6 3ABC RJ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
9051 ug/kg
TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria Skin and Appendages - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
50 mg/kg
TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria Lungs, Thorax, or Respiration - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
260 mg/kg
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Tumorigenic - tumors at site of application
TYPE OF TEST :
DNA adduct
TYPE OF TEST :
DNA adduct

MUTATION DATA

TYPE OF TEST :
DNA adduct
TEST SYSTEM :
Mammal - species unspecified Lymphocyte
DOSE/DURATION :
100 umol/L
REFERENCE :
CRNGDP Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- Volume(issue)/page/year: 15,1065,1994 *** REVIEWS *** IARC Cancer Review:Animal Limited Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 32,269,1983 IARC Cancer Review:Human No Adequate Data IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 32,269,1983 IARC Cancer Review:Group 3 IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year: 7,56,1987

Safety Information

[ Hazard Codes ]:
Xn

[ HS Code ]:
2902909090

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

  • 3-Hydroxy-3,4-dihydrocyclopenta(cd)pyrene
  • 1-(1-chloroethenyl)pyrene
  • 3,4,4a,5-tetrahydrocyclopenta[c,d]pyrene
  • cyclopenta[cd]pyren-3(4H)-one
  • Benzo(c)phenanthrene
  • Pyrene
  • Anthracene

DownStream

  • Pyrene
  • benzo(ghi)fluoranthene
  • cyclopenta[cd]pyren-3(4H)-one
  • 4-nitrocyclopentapyrene
  • 2,3-acepyrene

Customs

[ HS Code ]: 2902909090

[ Summary ]:
2902909090 other aromatic hydrocarbons。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:2.0%。General tariff:30.0%

Related Compounds

  • 6-nitrocyclopenta[cd]pyrene
  • Benzo[l]cyclopenta[cd]pyrene
  • cyclopenta[cd]pyrene 3,4-oxide
  • 3,4,4a,5-tetrahydrocyclopenta[cd]pyrene
  • 3,4-Dihydrocyclopenta[cd]pyrene-3,4-diol
  • 1H-4,6,8,10a-tetraazacyclopenta[cd]pyrene
  • 8-[(2E)-2-[(2-chlorophenyl)methylidene]hydrazinyl]-3-methyl-7-(2-phenylethyl)-4,5-dihydropurine-2,6-dione
  • 7-[(2-chlorophenyl)methyl]-8-[(2Z)-2-[1-(2-hydroxyphenyl)ethylidene]hydrazinyl]-1,3-dimethyl-5H-purin-7-ium-2,6-dione
  • N-(4-oxo-2-sulfanylidene-1,2,3,4-tetrahydroquinazolin-3-yl)-1,2,3-thiadiazole-4-carboxamide
  • 2-[2-(4-fluorophenyl)-5-oxo-5H,6H-[1,2,4]triazolo[1,5-c]quinazolin-6-yl]-N-(4-methylphenyl)acetamide
  • 5-methyl-3-phenyl-6-{2-[(pyridin-2-yl)amino]-1,3-thiazol-4-yl}-1H,2H,3H,4H-thieno[2,3-d]pyrimidine-2,4-dione
  • 1-(benzylsulfanyl)-4-[(4-methylphenyl)methyl]-5-oxo-N-(propan-2-yl)-4H,5H-[1,2,4]triazolo[4,3-a]quinazoline-8-carboxamide
  • 8-[(2E)-2-[(2-chloro-6-fluorophenyl)methylidene]hydrazinyl]-7-[(2-fluorophenyl)methyl]-3-methyl-4,5-dihydropurine-2,6-dione
  • 7-phenyl-2-(prop-2-en-1-yl)-2H,3H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazine-3,8-dione
  • 2-Benzyl-6-(4-ethylphenyl)-4-methyl-4a,7,8,9a-tetrahydropurino[7,8-a]imidazole-1,3-dione
  • 8-[(2E)-2-[(2-chloro-6-fluorophenyl)methylidene]hydrazinyl]-7-[(4-fluorophenyl)methyl]-1,3-dimethyl-5H-purin-7-ium-2,6-dione
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.